We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

118 hedge funds and large institutions have $264M invested in Albany Molecular Research Inc in 2013 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

82% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 28

15% more funds holding

Funds holding: 103118 (+15)

13% more call options, than puts

Call options by funds: $1.43M | Put options by funds: $1.26M

2% less capital invested

Capital invested by funds: $269M → $264M (-$4.3M)

Holders
118
Holders Change
+15
Holders Change %
+14.56%
% of All Funds
3.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
51
Reduced
28
Closed
9
Calls
$1.43M
Puts
$1.26M
Net Calls
+$169K
Net Calls Change
+$101K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
51
Millennium Management
New York
$550K +$659K +54,552 New
Arrowstreet Capital
52
Arrowstreet Capital
Massachusetts
$549K +$659K +54,513 New
Charles Schwab
53
Charles Schwab
California
$545K -$508K -42,000 -44%
FQ
54
First Quadrant
California
$513K +$62.8K +5,200 +11%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$424K +$4.83K +400 +1%
SIM
56
Spark Investment Management
New York
$407K +$129K +10,700 +36%
PP
57
PDT Partners
New York
$371K -$957K -79,204 -68%
TA
58
Teachers Advisors
New York
$359K +$36.5K +3,020 +9%
AL
59
Airain Ltd
Guernsey
$355K +$425K +35,185 New
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$349K -$26K -2,150 -6%
CIC
61
Cornercap Investment Counsel
Georgia
$348K
EMG
62
Ellington Management Group
Connecticut
$347K +$187K +15,500 +82%
NI
63
Numeric Investors
Massachusetts
$337K -$330K -27,301 -45%
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$318K -$38K -3,144 -9%
PCM
65
Prelude Capital Management
New York
$302K
SCM
66
Sterling Capital Management
North Carolina
$302K +$75.8K +6,274 +27%
WCM
67
Wedge Capital Management
North Carolina
$293K +$79.8K +6,600 +29%
Capital Fund Management (CFM)
68
Capital Fund Management (CFM)
France
$288K +$345K +28,544 New
Citadel Advisors
69
Citadel Advisors
Florida
$275K -$353K -29,251 -52%
Two Sigma Investments
70
Two Sigma Investments
New York
$269K +$323K +26,702 New
KeyBank National Association
71
KeyBank National Association
Ohio
$262K
RA
72
Raffles Associates
New York
$252K +$302K +25,000 New
OSAM
73
O'Shaughnessy Asset Management
Connecticut
$230K
NFA
74
Nationwide Fund Advisors
Ohio
$223K -$5.74K -475 -2%
LBC
75
Lawrence B. Cohen
$218K

AMRI Hedge Fund Activity: Q4 2013 in Review

118 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2013, worth a combined $264M — down 1.6% from $269M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AMRI positions and 9 closed out — a net gain of 15 holders — while 51 added to existing stakes and 28 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $28.4M. The largest seller was Fuller & Thaler Asset Management, exiting entirely with an estimated $4.57M sold.

  • 118 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2013, up from 103 in Q3 2013.
  • Funds reported $264M of Albany Molecular Research Inc stock for Q4 2013, down 1.6% quarter-over-quarter.
  • 24 funds opened new Albany Molecular Research Inc positions in Q4 2013 and 9 closed out, a net change of +15 holders.
  • The largest Albany Molecular Research Inc buyer in Q4 2013 was Wellington Management Group, an estimated $28.4M added.
  • The largest Albany Molecular Research Inc seller in Q4 2013 was Fuller & Thaler Asset Management, an estimated $4.57M sold.

Based on aggregated 13F filings for Q4 2013.